Late-Onset Retinal Degeneration Clinical Trials

Find Late-Onset Retinal Degeneration Clinical Trials Near You

Noninvasive Imaging Biomarkers of Treatable Macrovascular Disease in Age-related Macular Degeneration.

Status: Recruiting
Location: See location...
Study Type: Observational
SUMMARY

The purpose of this prospective study is to investigate whether ophthalmic artery stenosis (narrowing of the ophthalmic artery) contributes to the development and progression of geographic atrophy (GA), an advanced form of dry age-related macular degeneration (AMD).

Eligibility
Participation Requirements
Sex: All
Minimum Age: 50
Maximum Age: 80
Healthy Volunteers: f
View:

• 50-80 years of age

• All genders

• Asymmetric dry AMD with geographic atrophy in at least one eye and reduced disease severity in the other eye according to International Classification of Disease (ICD) codes

• Treated at the Cole Eye Institute, Cleveland Clinic, Cleveland, Ohio

Locations
United States
Ohio
Cleveland Clinic
RECRUITING
Cleveland
Contact Information
Primary
Sara Lautzenhiser Research Coordinator
LAUTZES@ccf.org
216-444-3026
Time Frame
Start Date: 2026-09-01
Estimated Completion Date: 2028-12
Participants
Target number of participants: 30
Sponsors
Leads: Scott Raymond

This content was sourced from clinicaltrials.gov